mRNA-based drugs are setting themselves apart from conventional protein rehabs in cell and gene gene, treatment, and vaccine modifying arenas. As researchers develop and manufacture unique mRNA therapies, they must find technologies that help examine their drug products on a big scale. Direct mRNA sequence mapping with mass spectrometry is an unique workflow for quickly fragmenting and assessing mRNA. Download this ebook from Thermo Fisher Scientific to discover mRNA therapies and the direct mRNA sequencing workflow.Sponsored by